Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Clinical trial NCT02998268 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02998268
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2021-02-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.